InvestorsHub Logo
Followers 15
Posts 2422
Boards Moderated 2
Alias Born 07/26/2003

Re: FORDGT post# 148

Monday, 04/13/2009 11:48:14 AM

Monday, April 13, 2009 11:48:14 AM

Post# of 232
Not clear if this is still pending:

SAN DIEGO, CA, and PARIS, FRANCE August 14, 2008 — Nanogen, Inc. (NASDAQ: NGEN), developer of molecular and rapid in vitro diagnostic products, and The Elitech Group, a private French diagnostics company, announced a definitive agreement to combine the two companies. The combination will create a global provider of products to the molecular, point-of-care, clinical chemistry and microbiology diagnostics markets with expected first year revenues of more than $150 million and positive EBITDA. The transaction combines Nanogen’s technology leadership in molecular and point-of-care diagnostics with the strong revenue and profit base stemming from The Elitech Group’s global manufacturing, sales and distribution of IVD products for the clinical chemistry and microbiology markets. The board of directors of both companies unanimously approved the agreement to combine the two companies.

http://www.nanogen.com/presscenter/pressreleases/5586/

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.